DUBLIN--(BUSINESS WIRE)--The "Veterinary/Animal Vaccines Market Analysis By Product (Attenuated Live, Inactivated, Subunit, DNA and Recombinant), By Animal Type (Companion Animal, Cattle, Poultry, Equine), And Segment Forecasts, 2014 - 2025" report has been added to ResearchAndMarkets.com's offering.
The global veterinary vaccines market is expected to reach USD 12.6 billion by 2025
Rise in the outbreak of livestock diseases, expanding livestock population and increasing zoonotic diseases are driving the market growth. Increasing awareness regarding commercially available vaccines is pushing the adoption globally. However, higher costs associated with storage is challenging the growth and restricting the entry of new players.
This market has emerged to be one of the profitable investment options seeking attention and investments from both government and non-government players. Rise in the number of pet owners and their shifting focus towards healthy animal practices are some other factors propelling the growth of the market.
Government intervention in distribution channel on the other hand, is affecting the profitability of the veterinary vaccine manufacturers. The bulk purchase and supply of livestock vaccines by countries such as India and Alaska that have large livestock population are reducing the profit margins of the vaccine manufacturers' through bulk pricing.
Key players including Zoetis, Virbac Inc. Indian Immunological Limited, Heska Corp., Boehringer Inghlem, Bayer Pharma Ag, Merck Animal Health and Biogenesis Bago dominated the global veterinary vaccines market.
Key Topics Covered:
Chapter 1 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Veterinary Vaccines Market Variables, Trends & Scope
Chapter 4 Veterinary Vaccines Market: Product Estimates & Trend Analysis
Chapter 5 Veterinary Vaccines Market: By Animal Type Estimates & Trend Analysis
Chapter 6 Veterinary Vaccines Market: Regional Estimates & Trend Analysis, by Product and Animal Type
Chapter 7 Competitive Landscape
- Merck & Co. Inc.
- Boehringer Ingelheim
- Bayer AG
- Virbac Inc.
- Biogenesis Bago S.A.
- Indian Immunological Limited
- Heska Corporation
For more information about this report visit https://www.researchandmarkets.com/research/dzhxq6/global?w=4